09:13:27 EDT Mon 22 Jul 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for C:APS from 2018-07-23 to 2019-07-22 - 37 items News ReleasesIn The NewsOther
DateSymCompanyPriceTypeHeadline
2019-07-16 08:50APSAptose Biosciences Inc (2)3.74News ReleaseAptose begins patient dosing in APTO-253 study
2019-06-14 07:56APSAptose Biosciences Inc (2)2.96News ReleaseAptose's CG-806 data to be subject of congress poster
2019-06-04 16:19APSAptose Biosciences Inc (2)2.62News ReleaseAptose Biosciences shareholders approve AGM resolutions
2019-06-03 11:16APSAptose Biosciences Inc (2)2.63News ReleaseAptose closes $21.3-million public offering
2019-06-03 11:00APSAptose Biosciences Inc (2)2.63News ReleaseAptose appoints Marango as chief business officer
2019-05-30 10:49APSAptose Biosciences Inc (2)2.75News ReleaseAptose Biosciences prices $18.5-million public offering
2019-05-29 16:29APSAptose Biosciences Inc (2)3.00News ReleaseAptose Biosciences arranges public offering of shares
2019-05-24 18:02APSAptose Biosciences Inc (2)2.71News ReleaseAptose files to sell up to $40-million (U.S.) on Nasdaq
2019-05-10 19:33APSAptose Biosciences Inc (2)2.91News ReleaseAptose begins $20M share purchase deal with Aspire
2019-05-07 18:49APSAptose Biosciences Inc (2)3.01SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2019-05-07 18:49APSAptose Biosciences Inc (2)3.01SEDAR MD & ASEDAR MD & A
2019-05-07 16:13APSAptose Biosciences Inc (2)3.01News ReleaseAptose spends $3.34-million on R&D in Q1
2019-04-23 08:16APSAptose Biosciences Inc (2)2.55News ReleaseAptose Biosciences to provide Q1 results on May 7
2019-04-01 13:08APSAptose Biosciences Inc (2)2.74News ReleaseAptose talks CG-806, APTO-253 preclinical data
2019-03-25 08:15APSAptose Biosciences Inc (2)3.10News ReleaseAptose granted IND allowance for CG-806 trial
2019-03-12 20:12APSAptose Biosciences Inc (2)2.30SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2019-03-12 20:12APSAptose Biosciences Inc (2)2.30SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2019-03-12 20:12APSAptose Biosciences Inc (2)2.30SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2019-03-12 20:05APSAptose Biosciences Inc (2)2.30SEDAR MD & ASEDAR MD & A
2019-03-12 20:05APSAptose Biosciences Inc (2)2.30SEDAR Annual ReportSEDAR Annual Report
2019-03-12 20:05APSAptose Biosciences Inc (2)2.30SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2019-03-12 16:15APSAptose Biosciences Inc (2)2.30News ReleaseAptose Biosciences spends $18.73-million in 2018
2019-03-04 08:22APSAptose Biosciences Inc (2)2.36News ReleaseAptose receives Australian patent for CG-806
2019-02-26 08:57APSAptose Biosciences Inc (2)2.53News ReleaseAptose Biosciences to release 2018 results March 12
2019-02-25 09:03APSAptose Biosciences Inc (2)2.59News ReleaseAptose Biosciences submits IND application for CG-806
2018-12-03 08:29APSAptose Biosciences Inc (2)3.03News ReleaseAptose presents CG-806 data at hematology meeting
2018-11-26 08:36APSAptose Biosciences Inc (2)2.88News ReleaseAptose begins dosing first patient for APTO-253 study
2018-11-06 18:07APSAptose Biosciences Inc (2)3.16SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2018-11-06 18:07APSAptose Biosciences Inc (2)3.16SEDAR MD & ASEDAR MD & A
2018-11-06 16:31APSAptose Biosciences Inc (2)3.16News ReleaseAptose Biosciences has R&D expenses of $3.59M in Q3
2018-10-23 08:32APSAptose Biosciences Inc (2)2.79News ReleaseAptose Biosciences to release Q3 2018 results Nov. 6
2018-09-27 09:15APSAptose Biosciences Inc (2)3.51News ReleaseAptose Biosciences receives European patent for CG-806
2018-08-15 08:05APSAptose Biosciences Inc (2)4.09News ReleaseAptose Biosciences appoints Ashe to board
2018-08-07 17:44APSAptose Biosciences Inc (2)3.58SEDAR MD & ASEDAR MD & A
2018-08-07 17:37APSAptose Biosciences Inc (2)3.58SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2018-08-07 16:34APSAptose Biosciences Inc (2)3.58News ReleaseAptose has R&D expenses of $7.81M (U.S.) in Q2
2018-07-24 08:15APSAptose Biosciences Inc (2)3.94News ReleaseAptose Biosciences to release Q2 2018 results Aug. 7